Overview
- Rigetti announced a letter of intent with the U.S. Department of Commerce on May 21 for up to $100 million under the CHIPS and Science Act with the Department to receive equity equal to the funding amount based on a formula tied to pre‑surge share prices discounted by 15%.
- The CHIPS funding is described as earmarked for superconducting quantum research to solve engineering challenges in scaling multi‑chip quantum processors.
- Separately, Rigetti said it will invest up to $100 million in the United Kingdom to pursue a superconducting system with more than 1,000 qubits within three to four years and to build on its existing 36‑qubit presence at the U.K. National Quantum Computing Center.
- Investors have driven a sharp rally in Rigetti stock as they view the announcements as validation that the company could become a national infrastructure supplier, but the shares have shown recent volatility after a 22.6% drop in July and still reflect a company with rising revenue, heavy R&D spending, and operating losses.
- Key risks remain because the CHIPS agreement is a letter of intent not a final award, the U.K. plan depends on British procurement timelines, the equity terms lock the government to a pre‑surge valuation, and the technical work to scale superconducting multi‑chip systems is difficult and multiyear.